Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference59 articles.
1. Woodworth K, Moulia D, Collins JP, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021. Centers for Disease Control and Prevention. Updated November 10, 2021. https://www.cdc.gov/mmwr/volumes/70/wr/mm7045e1.htm#suggestedcitation.[Accessed Februrary 17, 2022].
2. Wallace M, Woodworth, K, and Gargano J, et al. The Advisory Committee Immunization Practices' Intermin Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years. Centers for Disease Control and Prevention Updated 5/14/21. https://www.cdc.gov/mmwr/volumes/70/wr/mm7020e1.htm [Accessed September 23, 2021].
3. Summary of National Advisory Committee on Immunization (NACI) Statement of January 25, 2022: Updated Recommendations on the Use of COVID-19 Vaccines in Children 5 to 11 years of age. Public Health Agency of Canada. 2022. https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/summary.pdf. [Accessed 29 April 2022].
4. Swissmedic approves COVID-19 vaccine from Pfizer/BioNTech for children aged 5 to 11 years. Swissmedic 2021. https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/covid-19-impfstoff-pfizer-biontec-kinder-5-11-jahren-genehmigt.html. [Accessed 29 April 2022 ].
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献